Alkushi A - Search Results

1

Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma.

Irving JA, Alkushi A, Young RH, Clement PB. Irving JA, et al. Among authors: alkushi a. Am J Surg Pathol. 2006 Aug;30(8):929-38. doi: 10.1097/00000478-200608000-00001. Am J Surg Pathol. 2006. PMID: 16861962

2

Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.

Alkushi A, Irving J, Hsu F, Dupuis B, Liu CL, Rijn M, Gilks CB. Alkushi A, et al. Virchows Arch. 2003 Mar;442(3):271-7. doi: 10.1007/s00428-002-0752-4. Epub 2003 Feb 12. Virchows Arch. 2003. PMID: 12647218

3

Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.

Alkushi A, Abdul-Rahman ZH, Lim P, Schulzer M, Coldman A, Kalloger SE, Miller D, Gilks CB. Alkushi A, et al. Am J Surg Pathol. 2005 Mar;29(3):295-304. doi: 10.1097/01.pas.0000152129.81363.d2. Am J Surg Pathol. 2005. PMID: 15725797

4

Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases.

Gilks CB, Alkushi A, Yue JJ, Lanvin D, Ehlen TG, Miller DM. Gilks CB, et al. Among authors: alkushi a. Int J Gynecol Pathol. 2003 Jan;22(1):29-36. doi: 10.1097/00004347-200301000-00008. Int J Gynecol Pathol. 2003. PMID: 12496695

5

Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.

Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB. Al Kushi A, et al. Mod Pathol. 2002 Apr;15(4):365-71. doi: 10.1038/modpathol.3880531. Mod Pathol. 2002. PMID: 11950909

6

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Alkushi A, et al. Int J Gynecol Pathol. 2004 Apr;23(2):129-37. doi: 10.1097/00004347-200404000-00007. Int J Gynecol Pathol. 2004. PMID: 15084841

7

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB. Hsu FD, et al. Among authors: alkushi a. Mod Pathol. 2002 Dec;15(12):1374-80. doi: 10.1097/01.MP.0000039571.02827.CE. Mod Pathol. 2002. PMID: 12481020

8

Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.

Lim P, Al Kushi A, Gilks B, Wong F, Aquino-Parsons C. Lim P, et al. Cancer. 2001 Feb 15;91(4):752-7. Cancer. 2001. PMID: 11241243

9

High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.

Alkushi A, Köbel M, Kalloger SE, Gilks CB. Alkushi A, et al. Int J Gynecol Pathol. 2010 Jul;29(4):343-50. doi: 10.1097/PGP.0b013e3181cd6552. Int J Gynecol Pathol. 2010. PMID: 20567148

10

Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.

Woo MM, Alkushi A, Verhage HG, Magliocco AM, Leung PC, Gilks CB, Auersperg N. Woo MM, et al. Among authors: alkushi a. Clin Cancer Res. 2004 Dec 1;10(23):7958-64. doi: 10.1158/1078-0432.CCR-04-1261. Clin Cancer Res. 2004. PMID: 15585630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters